Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brazilian trial of amantadine for disorders of consciousness after aneurysmal subarachnoid hemorrhage
RBR-6789t4vPhase 3Recruiting
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in subarachnoid hemorrhage (SAH) comparing Amantadine with Placebo (2 arms). Started Jan 2020; status: recruiting.
02
Drugs
amantadine
03
Conditions
subarachnoid hemorrhage (SAH)
Beyond the preview
Go deeper on RBR-6789t4v.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6789t4v.